Gambia vs Paraguay: Access to anti-retroviral drugs, female
Gambia
55.0%
in 2024
Paraguay
55.0%
in 2024
Gambia rank
111th
Paraguay rank
111th
Access to anti-retroviral drugs, female over time
- Gambia
- Paraguay
How they compare
Gambia currently reports 55.0% against 55.0% in Paraguay, a difference of 0.0%.
Across all 25 years both countries report, Paraguay has been ahead every year.
Gambia ranks 111th and Paraguay ranks 111th of 141 countries.
Paraguay has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Gambia | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.6% | 6.1% | 4.5% | Paraguay |
| 2010s | 26.0% | 37.9% | 11.9% | Paraguay |
| 2020s | 48.0% | 52.4% | 4.4% | Paraguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Gambia or Paraguay?
- Gambia, at 55.0% against 55.0% in Paraguay as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Gambia and Paraguay?
- 0.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Paraguay?
- 25 years are reported by both, from 2000 to 2024.
- How do Gambia and Paraguay rank globally for access to anti-retroviral drugs, female?
- Gambia ranks 111th and Paraguay ranks 111th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.